Showdown: White House Cancels Pharma Meeting on International Pricing

On Tuesday, July 28, the White House abruptly canceled a meeting with drug company executives to discuss the most favored nation executive order, with a focus on the upcoming executive order to direct Medicare to tie Part B drug reimbursement to international prices.  A White House spokesperson said, “It’s unclear whether or when the meeting will be rescheduled.”

To read more, click here. (Source: InsideHealthPolicy, gated content)